MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Four-Week Trunk-Specific Exercise Program decreases Forward Trunk Flexion in Parkinson’s disease: a single- blinded, randomized controlled trial

    M. Gandolfi, M. Tinazzi, F. Magrinelli, G. Buselli, E. Dimitrova, N. Polo, P. Manganotti, A. Fasano, N. Smania, C. Geroin (Verona, Italy)

    Objective: The primary aim was to compare the effects of a four-week trunk-specific rehabilitation program on the severity of the forward trunk flexion. The secondary…
  • 2019 International Congress

    Hippotherapy for axial symptoms, gait and posture in people with Parkinson disease: A case report

    T. Mcisaac, J. Hayes, J. Goodman, O. Harpham, N. Erickson (Mesa, AZ, USA)

    Objective: To explore the feasibility and effects of equine-assisted intervention (hippotherapy) on axial symptoms underlying gait and balance in people with Parkinson disease (PD). Background: People with PD…
  • 2019 International Congress

    Stiff Limb Syndrome Progressing to Stiff Man Syndrome in a non-diabetic man

    T. Ali, D. Ginjupally, Z. Guduru (Lexington, KY, USA)

    Objective: Stiff person syndrome is a rare CNS disorder characterized by fluctuating muscle rigidity of truncal and proximal limb muscles with superimposed painful spasms. Involved…
  • 2019 International Congress

    A Study of Microglial Metabolism in Neuroinflammation

    T. Domenick, B. Cyr, R. Yost, M. Okun, V. Vedam-Mai (Gainesville, FL, USA)

    Objective: Targeting of microglial metabolism may be a potential therapeutic option for diseases such as PD [Parkinson’s Disease] and LBD [Lewy Body Dementia]. To establish…
  • 2019 International Congress

    Clinical Audit of Hospital Admissions for Parkinson Disease

    HL. Lan, LW. Wei, ST. Shu Ting, KY. Kay Yaw, WL. Wing Lok, LT. Louis Cs (Singapore, Singapore)

    Objective: To review Parkinson patients’ admissions and identify possible preventable admissions so as to develop measures to improve care for Parkinson patients Background: Many studies…
  • 2019 International Congress

    Investigation of the protective efficacy of alpha-synuclein-specific antibodies in a novel neuronal cell model for synucleinopathies

    A. Peukert, M. Höllerhage, W. Zago, G. Höglinger (Munich, Germany)

    Objective: To investigate the protective efficacy of different alpha-synuclein (α-Syn)-targeting antibodies in a new model of α-Syn cell-to-cell spread. Background: The 14 kDa protein α-Syn…
  • 2019 International Congress

    Wide distribution of alpha-synuclein oligomers in Creutzfeldt-Jakob disease detected by a novel proximity ligation assay

    R. Valenti-Azcarate, I. Martinez-Valbuena, C. Caballero, I. Marcilla Garcia, G. Marti, M. Carmona-Abellan, M. Tuñon-Alvarez, MR. Luquin-Piudo (Pamplona, Spain)

    Objective: The objective of this work is to assess if oligomeric forms of alpha-synuclein exist in patients with Creutzfeldt-Jakob disease. Background: Prion diseases, the most…
  • 2019 International Congress

    Baicalein incorporated nanoliposome disaggregates alpha-synuclein fibrils

    F. Aliakbari, D. Morshedi, H. Mohammad-Beigi, D. Otzen (Tehran, Islamic Republic of Iran)

    Objective: The aim of this study is to evaluate the depolymerization effect of baicalein on mature fibrils of alpha-synuclein. Background: The aggregation and oligomerization of…
  • 2019 International Congress

    GBA-LRRK2 Parkinson’s Disease: a clinical case

    L. Azevedo Kauppila, D. Pimenta Silva, A. Castro Caldas, M. Coelho, J. Ferreira, L. Correia Guedes (Lisboa, Portugal)

    Objective: Description of the phenotype of a Parkinson’s disease (PD) patient carrying mutations in both GBA and LRRK2 genes. Background: Monogenic PD due to LRRK2…
  • 2019 International Congress

    Carrier Mediated Delivery System Bearing Dopamine for Effective Management of Parkinsonism

    M. Bhargava, S. Bhargava (Kanpur, India)

    Objective: In the present investigation, amino acid coupled liposomes bearing dopamine-HCl were prepared to deliver drug to the brain utilizing receptor-mediated transcytosis for effective management…
  • « Previous Page
  • 1
  • …
  • 144
  • 145
  • 146
  • 147
  • 148
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • Effect of marijuana on Essential Tremor: A case report
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley